Shop

NovoMix 30 FlexPen (Insulin Aspart Biphasic 100IU/mL) is a premixed insulin formulation used for managing Type 1 and Type 2 Diabetes Mellitus. It combines 30% rapid-acting Insulin Aspart with 70% intermediate-acting protamine-crystallized Insulin Aspart, providing both immediate and prolonged blood sugar control.

Each pack contains 5 pre-filled FlexPens, with each pen holding 3ml of insulin (100IU/mL). The FlexPen device is user-friendly, offering accurate dosing and convenient on-the-go insulin administration. NovoMix 30 is designed to cover mealtime glucose spikes and maintain basal insulin levels throughout the day.

Patients typically administer NovoMix 30 subcutaneously before meals, with dosing frequency determined by individual blood glucose monitoring and physician recommendations. The pen allows for easy and precise dose adjustments to ensure effective glycemic control.

NovoMix 30 FlexPen provides:

Rapid onset of action (within 10-20 minutes)

Peak effect at 1-4 hours

Duration of action up to 24 hours

Common injection sites include the abdomen, thighs, or upper arms. Rotation of injection sites helps minimize the risk of lipodystrophy.

Possible side effects include hypoglycemia, local injection site reactions, and mild weight gain. Patients should monitor blood glucose regularly and carry a source of fast-acting sugar to treat potential hypoglycemia.

Unopened FlexPens should be stored in a refrigerator at 2°C to 8°C. Once in use, the pen can be kept at room temperature (below 30°C) for up to 28 days.